Pfizer

$43.16 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Stock Analysis

last close $43.16
1-mo return -1.8%
3-mo return 4.1%
avg daily vol. 21.24M
52-week high 51.86
52-week low 32.8
market cap. $232.6B
forward pe 10.8
annual div. 1.56
roe 19.7%
ltg forecast 12.4%
dividend yield 3.61%
annual rev. $51.6B
inst own. 67.4%
baraka

Subscribe now for daily local and international financial news

Subscribe